Keith Wai-Yeung Kwong

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Venues

Vaccines

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Keith Wai-Yeung Kwong, Ying Xin, Nelson Cheuk-Yin Lai, Johnny Chun-Chau Sung, Kam-Chau Wu, Yusuf Khwaja Hamied, Eric Tung-Po Sze, Dominic Man-Kit Lam
Oral Vaccines: A Better Future of Immunization. Vaccines 11 (7) (2023)
Ben Chung Lap Chan, Peiting Li, Miranda Sin-Man Tsang, Johnny Chun-Chau Sung, Keith Wai-Yeung Kwong, Tao Zheng, Sharon Sze-Man Hon, Ching-Po Lau, Wen Cheng, Fang Chen, Clara Bik San Lau, Ping Chung Leung, Chun-Kwok Wong
Creating a Vaccine-like Supplement against Respiratory Infection Using Recombinant Bacillus subtilis Spores Expressing SARS-CoV-2 Spike Protein with Natural Products. Molecules (Basel, Switzerland) 28 (13) (2023)
Johnny Chun-Chau Sung, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Keith Wai-Yeung Kwong
Retraction: Sung et al. Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 2022, 10 , 2. Vaccines 10 (11) (2022)
Johnny Chun-Chau Sung, Nelson Cheuk-Yin Lai, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Cheong-Nang Kuok, Wai-Leng Leong, Weng-Kei Lam, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Eric Tung-Po Sze, Keith Wai-Yeung Kwong
Safety and Immunogenicity of Inactivated Bacillus subtilis Spores as a Heterologous Antibody Booster for COVID-19 Vaccines. Vaccines 10 (7) (2022)
Johnny Chun-Chau Sung, Ying Liu, Kam-Chau Wu, Man-Chung Choi, Chloe Ho-Yi Ma, Jayman Lin, Emily Isabel Cheng He, David Yiu-Ming Leung, Eric Tung-Po Sze, Yusuf Khwaja Hamied, Dominic Man-Kit Lam, Keith Wai-Yeung Kwong
Expression of SARS-CoV-2 Spike Protein Receptor Binding Domain on Recombinant B. subtilis on Spore Surface: A Potential COVID-19 Oral Vaccine Candidate. Vaccines 10 (1) (2021)

Keith Wai-Yeung Kwong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Keith Wai-Yeung Kwong